Cargando…
52350 PKM2 mediates anti-tumor immunity and T cell dysfunction
ABSTRACT IMPACT: T cell dysfunction is a dominant suppressor of anti-tumor immunity, reducing immunotherapeutic efficacy and benefit to patients; our work will identify novel mediators of this process for both therapeutic potential and underlying mechanism, allowing for both potential immediate clin...
Autores principales: | Markowitz, Geoffrey, Ban, Yi, Crowley, Michael, Tavarez, Diamile, Wong, Stephen T.C., Chang, Kenneth, Schietinger, Andrea, Altorki, Nasser, Mittal, Vivek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827797/ http://dx.doi.org/10.1017/cts.2021.630 |
Ejemplares similares
-
Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve checkpoint blockade
por: Markowitz, Geoffrey J., et al.
Publicado: (2023) -
4581 Autonomic Dysfunction as a Marker of Depression and Coronary Artery Disease
por: Shah, Anish Sanjay
Publicado: (2020) -
2372: Metabolite and biomarker predictors of WTC-lung injury: An integrated multiplatform pilot analysis
por: Crowley, George, et al.
Publicado: (2018) -
4086 HIV-Associated Myocardial Diastolic Dysfunction and Soluble ST2 Concentration in Tanzanian Adults: A Cross-Sectional Study
por: Kingery, Justin, et al.
Publicado: (2020) -
4311 Inflammatory biomarkers of cognitive dysfunction in pediatric obesity: associations between Executive Function, C-Reactive Protein, Interleukin 6, and Tumor Necrosis Factor alpha
por: Prendergast, Kathryn, et al.
Publicado: (2020)